Although HDAC inhibitors have neuroprotective properties in animal models for various neurological diseases including Alzheimer's disease and ischaemic stroke 4, 5, current HDAC inhibitors are mostly nonselective, and different HDACs serve very distinct functions. The gene discussed is HDAC9; the disease is Alzheimer disease.